The growing problem of antibiotic resistance poses one of the greatest threats to modern medicine, making the search for new, alternative strategies to treat bacterial infections a matter of priority. The aim of the study was to evaluate the antimicrobial activity of selected postbiotic substances (PS) and nisin against methicillin-susceptible (MS) and methicillin-resistant (MR) strains of coagulase-negative staphylococci (NAS) and mammaliicocci. The study was conducted on 24 strains of coagulase-negative staphylococci and mammaliicocci isolated from milk collected from Holstein-Friesian (HF) cows with subclinical mastitis. In vitro, PS/EMo (100–400 AU/mL) and PS/Eas (100–200 AU/mL) were the most effective, inhibiting the growth of all MS and MR strains of NAS and Mammaliicoccus spp. (100.0%). A high percentage of strains were also sensitive to postbiotic substances produced by Lactococcus lactis subsp. lactis PS/MK2/8 (400–1600 AU/mL), PS/MK1/3 (100–400 AU/mL), and nisin (100–25,600 AU/mL), both in MR strains (94.1%, 82.4%, 88.2%, respectively) and in MS strains (100.0%, 85.7% and 100%, respectively). PS/Esach (100–25,600 AU/mL) inhibited the growth of all strains, including the mecA gene-positive mammaliicocci strains (100.0%), but was slightly less effective against the MS strains (64.7%). The lowest activity was observed with postbiotic substances produced by Enterococcus faecium, PS/4231 (100–1600 AU/mL) and PS/9296 (100–6400 AU/mL), which inhibited the growth of 3 out of 17 MR strains (17.65%). Among the Mammaliicoccus strains with the mecA gene, postbiotic substances derived from strains PS/4231 and PS/9296 inhibited the growth of 42.9% and 28.6% of the strains, respectively. Four tested strains were sensitive to all postbiotic substances (MSC9, MSC11, MSC12 and SCH3). This study confirms that postbiotic substances and nisin inhibit the growth of staphylococci isolated from the milk of cows with subclinical mastitis, including methicillin-resistant strains.